A body scan with Neko Health in London gave me a more refined look at my own health. I've already booked my next one.
A negative scan does not always mean recurrent prostate cancer is nowhere to be found. Sometimes, the disease may simply be ...
A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most ...
One of the biggest challenges in cancer research has been linking the "big picture" seen in medical scans with the ...
Zacks Investment Research on MSN
GEHC stock up on $500M strategic care alliance with Catholic Health
GE HealthCare GEHC recently announced a 10-year strategic Care Alliance with Catholic Health, valued at approximately $500 ...
Sun Nuclear, a Mirion Medical company, announced today the featured innovations in quality assurance (QA) for machine oversight and adaptive radiotherapy, as well as AI-assisted treatment planning, to ...
Medulloblastoma is the most common malignant embryonal tumor of the central nervous system in the pediatric population, ...
On Thursday, July 16, 2026, Catholic Health and GE HealthCare pulled the curtain back on a sweeping 10-year technology ...
Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX, "Telix") today announced completion of patient enrollment in the pivotal Phase 3 registration study of TLX591-Px (Illuccix®, Kit for the preparation of ...
GE HealthCare said it will partner with Catholic Health for 10 years, in a deal worth about $500 million, to expand advanced imaging, diagnostics and AI tools across the health system's Long Island ...
Every day, researchers at the University of Iowa are seeking answers to questions that will change the health and well-being ...
Telix Pharmaceuticals and St Vincent's Hospital announced the first patients have been dosed with TLX597-Tx in the OPTIMAL-e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results